## Note
nid: 1583978044450
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::MedicalArk, #AK_Step1_v11::#NBME::Free120, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Physeo::09_Pharm::16_Autonomic_Pharm::13_Atropine, #AK_Step1_v11::#UWorld::10000-99999::18000-18999::18622, #AK_Step2_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step2_v11::!Shelf::#Cards_AnKing_Skipped, #AK_Step2_v11::#OME::17_Surgical_Trauma::06_Toxic_Ingestion, #AK_Step2_v11::#Resources_by_rotation::IM::amboss_medicalark, #AK_Step2_v11::#Subjects::Surgery_&_EM::03_Toxicology::Organophosphate, #AK_Step2_v11::Original_decks::MedicalArk::im::amboss
markdown: false

### Text
In <b>organophosphate poisoning</b>, {{c1::atropine}} is given
first; {{c1::pralidoxime}} is given second

### Extra
- Pralidoxime has poor blood-brain barrier penetration and can lead
to a transient worsening of acetylcholinesterase inhibition
following administration, which is why atropine is typically
administered first to treat CNS symptoms and prevent further
acetylcholinesterase inhibition
<div>
  - Pralidoxime induces a transient increase in
  acetylcholinesterase inactivation, so administering the drug
  without pretreatment with another drug could cause an
  exacerbation of the patient's symptoms.
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

